Board of directors

Staffan Encrantz, Chairman – Mr. Encrantz is the Chairman and CEO of Allegro Investment Inc. and represents the owner of AnaMar. He is a private investor who has led the growth and development of a number of early stage businesses to highly successful realizations.

Anders Ekblom, MD, PhD, DDS, Associate Professor – Dr. Ekblom has substantial experience from senior positions in the biopharmaceutical industry. He has been the executive vice president of Global Medicines Development at AstraZeneca, and the CEO of AstraZeneca Sweden AB. Currently, he is a senior advisor for Phase4 Partners, and a board member for SwedenBio, a national organization for Sweden’s life science industry.

Denise Goode, BSc, ACA (ICAEW), MIoD – Mrs. Goode has extensive financial, commercial and industry dealmaking experience. She has served in senior leadership positions at Astra Zeneca. In 2014, she established QED Life Sciences Limited, a consultancy business through which she currently advises and supports the strategic direction of biotech clients. Currently, she is a senior advisor to Domainex Limited.